AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Coeptis Therapeutics Holdings, Inc.

$3.64 -$7.08 (-66.07%)
NASDAQ · 02 Nov 2026 15:37 UTC
Previous Close
$3.59
Day Range
$3.42$3.67
Year Range
$2.11$18.80
Market Cap
192.8M
AVG Volume
508.69K
Trailing/Forward PE
-2.05/-
PEG ratio
-0.02
Dividend Yield
-
Next Earnings Date
2026-12-02
Primary Exchange
NASDAQUS
Revenue (USD) · A
0500K1M1.5M20212022202320242025
ZSQR Revenue (USD) by year
PeriodRevenue (USD)
20251.36M
20240
20230
20220
20210
Net Income (USD) · A
-40M-20M020M20212022202320242025
ZSQR Net Income (USD) by year
PeriodNet Income (USD)
2025-10.91M
2024-10.88M
2023-21.27M
2022-37.57M
202115.23M
Operating Income (USD) · A
-40M-30M-20M-10M020212022202320242025
ZSQR Operating Income (USD) by year
PeriodOperating Income (USD)
2025-13.04M
2024-10.05M
2023-21.49M
2022-34.2M
2021-681.32K
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ZSQR

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 2 Dec 2026.

Coeptis Therapeutics Holdings, Inc.
ZSQR
Stockpicker

Video analysis: ZSQR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ZSQR

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.